Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
After hours 02:07:23 am | |||
| 362.44 USD | +0.96% |
|
324.60 | -10.44% |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 25,362 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 28.13% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 24,854 | 24,621 | 24,310 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 29.41% | -0.94% | -1.26% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 42.7x | 37.3x | 33.2x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 8.11x | 7.15x | 6.29x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.8x | 2.6x | 2.6x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.61x | 7.17x | 6.69x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.46x | 6.96x | 6.41x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 26.9x | 24.2x | 21.5x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 33.5x | 29.9x | 26.4x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 54.2x | 45.6x | 37.5x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.85% | 2.19% | 2.66% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.8774 | 0.9571 | 1.094 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.24% | 0.27% | 0.3% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.416 | 9.619 | 10.82 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.4% | 9.95% | 10.1% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,333 | 3,537 | 3,792 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 923.3 | 1,017 | 1,129 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 741.1 | 823.5 | 922 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 604.2 | 685.6 | 764.8 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -508.1 | -741.3 | -1,052 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 359.00 | 359.00 | 359.00 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,648 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 42.66x | 7.46x | 26.92x | 0.24% | 2.54TCr | ||
| 22.34x | 3.25x | 12.12x | 2.86% | 16TCr | ||
| 18.26x | 3.22x | 11.31x | 3.69% | 10TCr | ||
| 16.5x | 0.18x | 11.68x | 0.8% | 5.77TCr | ||
| 31.96x | 7.77x | 20.31x | 1.25% | 5.23TCr | ||
| 38.59x | 3.08x | 10.51x | 2.49% | 4.27TCr | ||
| 37.81x | 1.38x | 12.14x | 0.26% | 3.34TCr | ||
| 29.71x | 5.26x | 16.78x | -.--% | 2.81TCr | ||
| 48.05x | 6.45x | 20.7x | 0.45% | 2.1TCr | ||
| 23.26x | 3.41x | 12.24x | 1.25% | 2.06TCr | ||
| Average | 30.91x | 4.15x | 15.47x | 1.33% | 5.4TCr | |
| Weighted average by Cap. | 26.48x | 3.66x | 13.86x | 2.02% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















